ES330391A1 - Un procedimiento para la estabilizacion de 1,3-dihidro-7-nitro-5-fenil-2h-1,4-benzodiazepin-2-ona. - Google Patents

Un procedimiento para la estabilizacion de 1,3-dihidro-7-nitro-5-fenil-2h-1,4-benzodiazepin-2-ona.

Info

Publication number
ES330391A1
ES330391A1 ES0330391A ES330391A ES330391A1 ES 330391 A1 ES330391 A1 ES 330391A1 ES 0330391 A ES0330391 A ES 0330391A ES 330391 A ES330391 A ES 330391A ES 330391 A1 ES330391 A1 ES 330391A1
Authority
ES
Spain
Prior art keywords
benzodiazepin
dihydro
nitro
stabilization
translation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0330391A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES330391A1 publication Critical patent/ES330391A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heat-Exchange Devices With Radiators And Conduit Assemblies (AREA)
ES0330391A 1965-08-20 1966-08-19 Un procedimiento para la estabilizacion de 1,3-dihidro-7-nitro-5-fenil-2h-1,4-benzodiazepin-2-ona. Expired ES330391A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1177965 1965-08-20

Publications (1)

Publication Number Publication Date
ES330391A1 true ES330391A1 (es) 1967-10-16

Family

ID=4376790

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0330391A Expired ES330391A1 (es) 1965-08-20 1966-08-19 Un procedimiento para la estabilizacion de 1,3-dihidro-7-nitro-5-fenil-2h-1,4-benzodiazepin-2-ona.

Country Status (14)

Country Link
JP (1) JPS507079B1 (da)
BE (1) BE685589A (da)
DE (1) DE1617513C3 (da)
DK (1) DK111277B (da)
ES (1) ES330391A1 (da)
FI (1) FI45726C (da)
FR (1) FR6063M (da)
GB (1) GB1101366A (da)
IL (1) IL26306A (da)
IT (1) IT1053660B (da)
MY (1) MY6900059A (da)
NL (1) NL6610569A (da)
NO (1) NO120752B (da)
SE (1) SE351978B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020032245A1 (en) * 2000-07-27 2002-03-14 Lyn Hughes Resinate composition
US20020031490A1 (en) * 2000-07-27 2002-03-14 Bellamy Simon Andrew Method for preparing resinates
US20030059397A1 (en) * 2001-09-17 2003-03-27 Lyn Hughes Dosage forms
EP1467769B1 (en) * 2002-01-18 2008-05-28 Rohm and Haas Company Use of a resinate in the preparation of a formulation for smoking cessation

Also Published As

Publication number Publication date
GB1101366A (en) 1968-01-31
JPS507079B1 (da) 1975-03-20
DE1617513A1 (de) 1970-12-23
SE351978B (da) 1972-12-18
NO120752B (da) 1970-11-30
IT1053660B (it) 1981-10-10
FI45726B (da) 1972-05-31
FI45726C (fi) 1972-09-11
BE685589A (da) 1967-02-17
DE1617513C3 (de) 1974-04-18
NL6610569A (da) 1967-02-21
DK111277B (da) 1968-07-15
IL26306A (en) 1970-02-19
FR6063M (da) 1968-05-27
DE1617513B2 (de) 1973-08-16
MY6900059A (en) 1969-12-31

Similar Documents

Publication Publication Date Title
CA937518A (en) Process for producing l-lysine
CA934934A (en) Process for producing hydrogen peroxide
ES330391A1 (es) Un procedimiento para la estabilizacion de 1,3-dihidro-7-nitro-5-fenil-2h-1,4-benzodiazepin-2-ona.
YU35126B (en) Process for producing ans-triazolo(1,5-a) (1,4)benzodiazepine derivative
CA928642A (en) Process for regenerating adsorption masses
CA919320A (en) Separating ion exchange resin beds
PH11202A (en) Process for producing triazolo-(4,3-a)(1,4)benzodiazepine derivatives
CA807591A (en) Process for producing hydrogen
CA807182A (en) Process for producing epoxy compounds
CA827144A (en) Process for producing 1,4-benzodiazepines
AU432304B2 (en) Process for producing l-lysine
CA676547A (en) Molecular sieve adsorption process
CA583328A (en) PROCESS FOR PRODUCING .alpha.-PHENYL SUCCINIMIDES
CA571728A (en) PROCESS FOR PRODUCING .alpha.-PHENYL SUCCINIMIDES
CA820611A (en) Process for continual stretch forming
CA818557A (en) PROCESS FOR PURIFYING BIS (.beta.-HYDROXYETHYL)TEREPHTHALATE
CA715066A (en) Process for regenerating an adsorbent mass
AU273590B2 (en) Process for regenerating an adsorbent mass
AU5157769A (en) Process for producing l-lysine
CA672617A (en) Process for making n-methyl pyrrole
CA667237A (en) Process for making carbon articles
CA823104A (en) Process for purifying benzene-containing hydrogen cyanide
CA675922A (en) Adsorption process
CA577105A (en) Process for conditioning polyamide resins
CA572022A (en) Process for preparing low density gels